Trexquant Investment’s Madrigal Pharmaceuticals MDGL Stock Holding History

Trexquant Investment’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.12M	Buy	+5,815	New	+$2.98M	0.02%	982
2026 Q1	–	Sell	-7,784	Closed	-$4.53M	–	1930
2025 Q4	$4.53M	Buy	+7,784	New	+$3.98M	0.04%	641
2023 Q3	–	Sell	-6,460	Closed	-$1.49M	–	1674
2023 Q2	$1.49M	Buy	6,460 +1,000	+18%	+$271K	0.04%	605
2023 Q1	$1.32M	Sell	5,460 -5,730	-51%	-$1.56M	0.04%	615
2022 Q4	$3.25M	Buy	+11,190	New	+$1.09M	0.09%	292
2021 Q3	–	Sell	-2,080	Closed	-$203K	–	1348
2021 Q2	$203K	Buy	+2,080	New	+$246K	0.02%	904
2020 Q4	–	Sell	-2,452	Closed	-$291K	–	1309
2020 Q3	$291K	Sell	2,452 -1,879	-43%	-$204K	0.02%	936
2020 Q2	$490K	Sell	4,331 -702	-14%	-$69K	0.03%	681
2020 Q1	$336K	Buy	+5,033	New	+$419K	0.02%	814

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Trexquant Investment's MDGL Position: Q2 2026 in Review

Trexquant Investment opened a new position in Madrigal Pharmaceuticals (MDGL) in Q2 2026: 5,815 shares worth $3.12M. The stake represents 0.02% of the portfolio and ranks #982 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in MDGL as recently as Q4 2025.

Trexquant Investment first reported a position in MDGL in Q1 2020 and has held it in 9 quarters since. The position peaked at $4.53M in Q4 2025. 415 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

Trexquant Investment held 5,815 shares of Madrigal Pharmaceuticals worth $3.12M as of Q2 2026.
Madrigal Pharmaceuticals was a new Trexquant Investment position in Q2 2026.
Madrigal Pharmaceuticals made up 0.02% of Trexquant Investment's portfolio in Q2 2026, its #982 holding.
Trexquant Investment first reported a position in Madrigal Pharmaceuticals in Q1 2020 and has held it in 9 quarters since.
Trexquant Investment's Madrigal Pharmaceuticals position peaked at $4.53M in Q4 2025.
415 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.